@drjessemorse post

Audited July 19, 2026 · Post from Apr 3, 2026

Supported

Five of six claims are directly supported by credible scientific literature. Claims 1, 2, 5, and 6 rest on well-established biochemistry and clinical evidence (semaglutide RCTs, insulin biology, oxytocin neurobiology, peptide signaling fundamentals). Claim 3 (TB-500 for ligament/tendon healing) is supported by preclinical animal studies and mechanistic literature, though human safety and efficacy data remain limited. Claim 4 (BPC-157) is moderately overstated: while decades of preclinical research exist and early human trials for IBD were conducted, the evidence base for musculoskeletal healing in humans is not yet robust, and BPC-157 remains unapproved. Creators accurately describe peptide biology but should clarify that strong preclinical support does not equal established human clinical efficacy.

Share this audit

One link — full verdict, every claim, and PubMed citations included.

peptiq.io/check/7a45daae

Shareable link includes the full verdict, claims, and PubMed citations.

Post captionshow

Peptides: Introduction and Breakdown! Curious about peptides and why everyone is talking about them? In this video, Dr. Morse breaks down everything you need to know in a simple, easy-to-understa...

Video transcriptshow

Hey guys, Dr. Morse here. So, a lot of people talking about peptides and have a lot of questions. So, here's going to be a little bit of a summary, introduction, and the many things to come. So, first of all, what are they? Peptides are small proteins in the body. They are work as signals. Go here and do this. Go here and do that. There's thousands of them, probably between 3 and 7,000 of them in

Show full video transcript

the body. And realistically, they've been around for a very long time. We identified them initially in the 1800s, and then eventually in the 1900s, there was a lot of work on them, predominantly in Russia and in Germany. Dr. Khavinson was one of the pioneers. He was actually Putin's personal doctor in Russia for many, many, many years. And he was an integral part of growing this space, and eventually Germany got even more into it, and then eventually the rest of the world found out. Now, these have been in the biohacking and health and longevity space for 20-30 years. But about 10-15 years ago, they started getting more steam, and then eventually Big Pharma started to catch some of them, put carbon groups on them, patent them, and then eventually run them through drug trials. That's when Ozempic was made. That was one of the first major peptides that became a drug. Ozempic is semaglutide, and the potency is about a thousand times stronger than the body actually makes. Anything at a thousand times is going to obviously have a lot of side effects and going to have a lot of issues. But, no question, it's effective, but just like anything, you have to understand how to use it. But, one of the things that's fascinating about peptides is that they are small proteins in the body. They are meant to do something. Go here and do this. Insulin is a peptide. Oxytocin, the hormone that boosts when you hug someone, is a peptide. Their goal is to do something. So, they are actually the workers inside of the body. So, when you get an injury, the first thing that is called for is something called thymosin beta-4 or TB-500. That is a signal to start the chain of starting to heal things. So, that would be a good one for injuries, for helping with ligaments and tendons. Now, the most famous peptide, at least for, you know, traditional use, is called BPC-157. It's actually made in the stomach naturally. It has tons of data going back 30-40 years, but no drug company has completed significant drug trials. Now, there's about 50 to 70 that are actually drugs here in the United States, and many of them are are are individual drugs, but in general, most of them are not drugs. Now, there's about 20 of them that are very common and a lot of people know, and there's about another 30 or 40 that will eventually become very common. Now, back in September of 2023, the FDA banned 19 peptides that were pretty much all injectable, used for various different things. BPC-157 injectable was on that list. Now, the important thing to understand is there was no reason, per se, why they banned it. They just banned it, and they made it from a category one, easy and safe to compound, to a category two, very difficult and not possible to compound without a lot of regulations. Now, I've personally been prescribing peptides to my patients since 2020. Nothing has changed, but I also have the luxury of access, and I had the luxury of places that are still available and have been available. But, that all is about to change in probably the next month or two. We don't have specifics right now, but RFK, about a month to six weeks ago, went on Joe Rogan's podcast and said, "Hey, the 14 of those 19 peptides that were banned are now going to be available and re-released again." But, they're only going to be through peptide compounding pharmacies, and really, ideally, not from the black and gray market, predominantly China, that has been created as result of that 2023 ruling. The supply disappeared, but the demand didn't, so companies made up the demand and made up the supply, and as result, you have millions of bottles shipped to the United States every year through these random places, but the problem is, what's the quality? What's the purity? Are there any endotoxins? You know, are these made in legitimate labs or these kind of scary places you really wouldn't want to see? Are they just one company, and then people actually just white label them into their own brand? So, you have all these different subtle things. The other question that people have is, are these safe to take? Which ones can I mix? When do I do them? Do I do them in the morning, in the afternoon, at night? Can I mix them with XYZ medicine? Which ones can you stack together, and which ones need to be done separately? Which labs should I check? And which ones should I do if I have cancer? Do any of them cause cancer? So, there's a lot more questions than people have answers, or at least most people. Most physicians have basically zero experience with peptides. Now, I happen to be one of the few who has a fair amount. I'm not the world's renowned expert on peptides, but I'm much more comfortable than probably 95% of physicians. With that being said, the field has to significantly improve in terms of a knowledge and experience for this, and I'm working on something that will be part of that. But, the important thing to understand is this is a brand new class of medicines available to help with things. People are are are much more into taking care of their own health now, and not depending on a physician, not present pretending on depending, excuse me, on, you know, Big Pharma, Big Insurance, or whoever, to check a med or see them for 10 minutes or or whatever. They want to take their health in their own hands, which is great, but you need someone to help you. Cuz if not, you're basically playing doctor and kind of playing with fire. What if you mix the wrong dose? What dose should you do? What is a safe dose, and what is a risky dose? What if you have a side effect? Who do you go to? How do What What do you do? Do you consider doing that one again? So, there's all these different questions, and that's part of the tricky part about peptides. Are they amazing? Yes. Do they have risk? Yes, just like anything. But, you have to find a physician that understands how to use these, a quality source, and overall, I feel like in general, we are working on that. We are working on decreasing costs, increasing not only information, but also proper protocols, proper training, and also making sure patients get access to these readily without having to jump through hoops or spend a lot of money. And in general, that is where this industry is going, and it's very, very quickly. In general, 503A pharmacies are compounded specifically for you. 503B compounding pharmacies or pharmacies are usually shipped in general, not specific for you. The quality is very similar, obviously depending on where it's made, but in general, it depends. Some of them are pre-liquid, already liquid. Some are going to be lyophilized in a powdered form, and then you have to mix it. So, there's a lot of moving parts. We just saw the the government basically seizes a shipment. I think it was in Cincinnati. Probably wasn't the first time. Definitely won't be the last time. And we will start to see more of this, more and more. And then remember, Big Pharma is going to push back hard. They're losing billions of dollars in some capacity on these, whether it's the GLP-1s, whether it's BPC, or any of these other medicines. And we're going to start to see, "Hey, there are genetic links that you can evaluate genetics and actually help to decide which peptides are perfect for that patient, which ones will benefit them the most." There are certain labs you should check that say, "Hey, what which ones are a best fit for me?" So, there's a lot of moving parts, and this is just basically a in-depth introduction into peptides. I will have a lot more for you. I will be working with a company called Stack that will basically provide a lot of this information and try to centralize it in one spot, safely and importantly. And then I'll also be working on a education peptide certification course, initially for physicians, to get them properly trained. And if you're interested, you can feel free to reach out, and I will make sure you get access to that. But, in general, hopefully that was helpful. Thank you for tuning in. I'm Dr. Jesse Morse.

Show less

Claim breakdown

6 claims
1

Peptides are small proteins in the body that work as signals, telling other parts of the body what to do.

Supported

The claim aligns with foundational biochemistry and peptide biology. PeptIQ internal knowledge defines peptides as 'short chains of amino acids...that function as signaling molecules in the body, triggering specific biological responses.' While no specific PubMed citations were retrieved for this exact framing, the concept is core to peptide pharmacology and supported across all referenced peptide literature (TB-500, BPC-157, semaglutide studies all operate on this signaling premise).

2

Ozempic (semaglutide) is a peptide that became a drug and is effective for its intended purpose.

Supported

Semaglutide is a GLP-1 receptor agonist peptide that is FDA-approved and extensively studied for weight management and glycemic control. PeptIQ internal references cite the STEP 1 trial (Wilding JPH et al., NEJM 2021, PMID: 33567185) and SELECT trial (Lincoff AM et al., NEJM 2023, PMID: 37952131), both demonstrating efficacy in human randomized controlled trials. The clinical trials retrieved (NCT06820047, NCT06981936, NCT05606471) further confirm active investigation into semaglutide's metabolic effects.

3

Thymosin beta-4 (TB-500) is called for when there is an injury to start the healing process, and is good for helping with ligaments and tendons.

Supported

Preclinical and animal evidence supports the claim. The 2026 Mendias & Awan narrative review (PMID: 41966639, published in Sports Med) explicitly addresses thymosin beta-4 (Tβ4) and TB-500, noting that 'many unapproved peptides demonstrate favorable tissue repair and metabolic outcomes in animal models.' The 2012 equine study (PMID: 22962027, Ho EN et al., J Chromatogr A) documents TB-500's mechanism as promoting 'endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decrease inflammation.' However, the review also emphasizes that 'rigorous human safety data are scarce' for TB-500 specifically.

4

BPC-157 is made in the stomach naturally and has tons of data going back 30-40 years, suggesting it accelerates healing and other beneficial effects.

⚠️Overstated

BPC-157 has been studied for decades with consistent preclinical support, but the claim overstates the maturity of human evidence. Two foundational studies (Sikiric et al., Inflammopharmacology 2006, PMID: 17186181; Sikiric et al., Curr Pharm Des 2010, PMID: 20166993) document BPC-157's cytoprotective and wound-healing effects primarily in rat models and clinical trials for inflammatory bowel disease (PL-10, PLD-116). The 2026 Mendias & Awan review (PMID: 41966639) categorizes BPC-157 as an 'unapproved' peptide with 'favorable outcomes in animal models' but explicitly warns that 'rigorous human safety data are scarce.' No registered human clinical trials for musculoskeletal injury were found.

5

Insulin is a peptide.

Supported

Insulin is biochemically and clinically established as a peptide hormone. Multiple PubMed abstracts confirm this: Jones & Hattersley (Diabet Med 2013, PMID: 23413806) discusses C-peptide measurement as equal to insulin secretion from pancreatic beta cells; Marques et al. (Pancreas 2004, PMID: 15367890) details insulin biosynthesis and C-peptide cleavage. Insulin is a 51-amino-acid peptide produced by the pancreatic islet beta cells and is one of the most well-characterized peptide hormones in human physiology.

6

Oxytocin, the hormone that boosts when you hug someone, is a peptide.

Supported

Oxytocin is a well-established nonapeptide (9 amino acids) hormone synthesized in the hypothalamus and released during social bonding, physical contact, and other stimuli. While the specific PubMed search returned no abstracts, three registered clinical trials were found (NCT01066299, NCT06194851, NCT02849743), confirming active human research into oxytocin's effects on behavior, stress, and metabolism. Oxytocin's peptide status and social/bonding release mechanism are established neurobiology.

Audit another post

Instagram, TikTok, X, Reddit, or paste text directly.

New audit

Track your protocols

Dosing, logging, and reminders in the app.

Get the app

This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.

Report an error